Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/MERCK-CO-INC-13611/news/Merck-and-Eisai-Provide-Update-on-Phase-3-LEAP-010-Trial-Evaluating-KEYTRUDA-pembrolizumab-Plus-44699051/?utm_source=whatsapp&utm_medium=social&utm_campaign=share